A Feasibility Study Monitoring the Respiratory Status of Participants Receiving or Scheduled to Receive Intrathecal Baclofen (ITB)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Intrathecal Baclofen
- Sponsor
- Solent NHS Trust
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Overnight home polysomnography
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The methodology is a feasibility study to determine the feasibility of assessing people in the community with a neurological condition before proceeding towards a full powered community trial evaluating the influence of intrathecal baclofen.
Detailed Description
The purpose of this proposed research will evaluate a feasible method to assess the respiratory status of people with neurological conditions receiving or scheduled to receive Intrathecal Baclofen. The use of Intrathecal Baclofen to manage severe spasticity is a developing treatment option with a limited research base, particularly when evaluating the influence of intrathecal baclofen on the respiratory system. The proposed research is derived from clinical practice and involves joint collaboration between clinical team, research professionals and patients. In order for the study to evaluate the influence of Intrathecal baclofen has on the respiratory system, the proposed research will need to develop and evaluate a method of assessing people in the community ensuring it's feasible for people with neurological conditions. Prior to implementing a full powered community trial to evaluate the influence of intrathecal baclofen on people with neurological conditions.
Investigators
Eligibility Criteria
Inclusion Criteria
- •-Adults over the age of 18
- •A person who is able to provide consent or a family member/ close friend who is able to assent on behalf of the participant
- •A person or a family member/ close friend who is able to understand English (understand written English and spoken instructions)
- •A person currently receiving Intrathecal Baclofen or is scheduled to receive Intrathecal Baclofen (awaiting fitting of pump) therapy to manage spasticity
- •A patient of the Solent/ University Hospitals Southampton NHS Foundation Trust Intrathecal baclofen service
Exclusion Criteria
- •-Pre-existing use of overnight non-invasive ventilation (NIV) and is compliant with NIV treatment
- •A person who is unable to consent to the study and does not have a family/ close person to assent
- •The study will exclude a person who is unable to independently remove the polysomnography and is also without supervision from another person (carer or partner) during the night. This ensures the participant is able to take off the polysomnography (or assisted by a carer) if it becomes uncomfortable and/or causes distress.
Outcomes
Primary Outcomes
Overnight home polysomnography
Time Frame: 2 nights
sleep study
Secondary Outcomes
- Sniff nasal inspiratory pressure Expiratory and inspiratory mouth pressures Cough peak flow Expanded disability status scale Epworth sleepiness scale Semi Structured interview(2 nights)